Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
A
Aarti Drugs Ltd
Score 68/100• Decent
Aarti Drugs Ltd shows potential for growth but faces several risks that could impact its performance.
Company’s Health73/100
Valuation 60/100 · PB 2.6308
Technical Avoid
1M -17.582% 6M -16.66% 1Y -11.562%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#121
View details ➜
A
Aatmaj Healthcare Ltd
Score 68/100• Decent
Aatmaj Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health83/100
Valuation 100/100 · PB 0.8725
Technical Avoid
1M -3.491% 6M 0.519% 1Y -28.333%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#122
View details ➜
Q
Quest Laboratories Ltd
Score 66/100• Decent
Quest Laboratories Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health90/100
Valuation 80/100 · PB 1.7537
Technical Avoid
1M 1.706% 6M -2.288% 1Y -21.83%
Confidence100%
Low leverage (D/E)No promoter pledge
#123
View details ➜
K
Krishna Institute of Medical Sciences Ltd
Score 66/100• Decent
The stock shows decent potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health82/100
Valuation 20/100 · PB 10.9605
Technical Avoid
1M -1.856% 6M 0.189% 1Y 10.453%
Confidence100%
No promoter pledgeHealthy profit margins
#124
View details ➜
M
MedPlus Health Services Ltd
Score 66/100• Decent
MedPlus Health Services Ltd shows potential for growth, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health52/100
Valuation 20/100 · PB 5.5382
Technical Avoid
1M 6.882% 6M -9.52% 1Y -4.759%
Confidence100%
Weak ROEPromoter pledge present
#125
View details ➜
Y
Yatharth Hospital & Trauma Care Services Ltd
Score 66/100• Decent
Yatharth Hospital shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health71/100
Valuation 40/100 · PB 4.1228
Technical Avoid
1M -8.889% 6M 33.785% 1Y 12.557%
Confidence100%
Low leverage (D/E)Healthy profit margins
Weak ROEPromoter pledge present
#126
View details ➜
T
Torrent Pharmaceuticals Ltd
Score 66/100• Decent
Torrent Pharmaceuticals shows decent potential with a solid business model and growth prospects, but faces challenges in profitability and valuation metrics.
Company’s Health90/100
Valuation 20/100 · PB 16.9051
Technical Watch
1M -0.578% 6M 16.347% 1Y 13.932%
Confidence100%
Low leverage (D/E)No promoter pledge
#127
View details ➜
J
Jeevan Scientific Technology Ltd
Score 66/100• Decent
Jeevan Scientific Technology Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health63/100
Valuation 80/100 · PB 1.9654
Technical Avoid
1M -0.328% 6M 58.325% 1Y 24.025%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#128
View details ➜
T
Titan Biotech Ltd
Score 66/100• Decent
Titan Biotech Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
Company’s Health92/100
Valuation 20/100 · PB 5.8605
Technical Watch
1M 12.497% 6M 152.736% 1Y 35.017%
Confidence100%
Low leverage (D/E)No promoter pledge
#129
View details ➜
S
Star Imaging and Path Lab Ltd
Score 66/100• Decent
Star Imaging and Path Lab Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
Company’s Health97/100
Valuation 40/100 · PB 4.0037
Technical Avoid
1M -22.535% 6M -20.154% 1Y -20.154%
Confidence100%
No promoter pledgeHealthy profit margins
#130
View details ➜
S
Sanofi India Ltd
Score 66/100• Decent
Sanofi India Ltd shows a decent investment opportunity with a solid business model and growth potential, though some risks remain.
Company’s Health97/100
Valuation 20/100 · PB 11.3526
Technical Avoid
1M -7.767% 6M -31.273% 1Y -31.172%
Confidence100%
Low leverage (D/E)No promoter pledge
#131
View details ➜
P
Parmax Pharma Ltd
Score 66/100• Decent
Parmax Pharma Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health46/100
Valuation 100/100 · PB -6.3245
Technical Avoid
1M -12.684% 6M -13.5% 1Y -25.244%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#132
View details ➜
N
Nephro Care India Ltd
Score 66/100• Decent
Nephro Care India Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health83/100
Valuation 40/100 · PB 3.5768
Technical Avoid
1M -17.701% 6M -11.243% 1Y -43.842%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#133
View details ➜
A
Anthem Biosciences Ltd
Score 66/100• Decent
Anthem Biosciences Ltd shows potential but faces challenges in growth consistency and profitability metrics.
Company’s Health100/100
Valuation 20/100 · PB 16.3004
Technical Avoid
1M 0.058% 6M -4.231% 1Y -4.231%
Confidence100%
Low leverage (D/E)No promoter pledge
#134
View details ➜
H
Healthcare Global Enterprises Ltd
Score 66/100• Decent
Healthcare Global Enterprises Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
Company’s Health43/100
Valuation 20/100 · PB 10.1854
Technical Avoid
1M -5.566% 6M 31.22% 1Y 44.416%
Confidence100%
Decent revenue growth
Weak ROEHigh debt/equity
#135
View details ➜
Showing 121 to 135 of 301 (21 Pages)